Candida albicans is a fungal component of the gut microbiota in humans and many other mammals. Although C. albicans does not cause symptoms in most colonized hosts, the commensal reservoir does serve as a repository for infectious disease, and the presence of high fungal titers in the gut is associated with inflammatory bowel disease. Here, we describe a method to visualize C. albicans cell morphology and localization in a mouse model of stable gastrointestinal colonization. Colonization is established using a single dose of C. albicans in animals that have been treated with oral antibiotics. Segments of gut tissue are fixed in a manner that preserves the architecture of luminal contents (microorganisms and mucus) as well as the host mucosa. Finally, fluorescent in situ hybridization is performed using probes against fungal rRNA to stain for C. albicans and hyphae. A key advantage of this protocol is that it allows for simultaneous observation of C. albicans cell morphology and its spatial association with host structures during gastrointestinal colonization.
Introduction
Candida albicans is a fungal commensal as well as an opportunistic human pathogen. This yeast lacks a defined environmental niche and instead propagates within the gastrointestinal (GI) tract, skin, and genitourinary tract of humans and other mammals 1 . Whereas early research on C. albicans focused primarily on its virulence potential, several recent reports suggest that commensally propagating organisms within the gut may play important roles in normal health, including the immune development of the host 2, 3, 4 . To facilitate investigations of C. albicans commensalism within the mammalian gut, we developed a mouse model of stable GI colonization and a fluorescence in situ hybridization (FISH)-based method to visualize fungal yeast cells and hyphae within the intestinal lumen.
With some exceptions 5 , laboratory-bred mice typically exhibit resistance to fungal colonization of the digestive tract. Colonization resistance is thought to be mediated by specific bacterial species; however, this can be overcome by treatment of the animals with antibiotics 6, 7 or use of a chemically-defined diet that presumably alters bacterial species composition 8, 9 . Similarly, in humans, the use of broad-spectrum antibiotics has been associated with C. albicans overgrowth and dissemination 10 . Our murine colonization model uses broad-spectrum antibiotics to establish C. albicans colonization of immunocompetent, conventionally reared mice. Penicillin and streptomycin are provided in the animals' drinking water for one week prior to gavage with 10 8 colony forming units (CFUs) of C. albicans. As long as the antibiotic-infused water is continued, C.
albicans will propagate through the GI tract, reaching fecal titers of 10 6 −10 8 CFUs/g. Despite the high level of fungal colonization, animals remain healthy and gain weight at the same rate as uninfected controls. This model has been used successfully to screen for and characterize multiple C. albicans commensalism factors 11, 12 .
Like other members of the fungal kingdom, C. albicans is capable of enormous morphological plasticity 13 . Under in vitro conditions, it has been shown to transition among at least six unicellular yeast cell types, as well as multicellular hyphae and pseudohyphae. The yeast-to-hypha transition is one of its best-characterized virulence attributes, and hyphae and pseudohyphae predominate in most mammalian disease models, as well as in infected human tissues. To determine C. albicans localization and cell morphology within the murine digestive tract, we developed a FISH technique for staining yeasts and hyphae in fixed histological sections. The probes consist of fluorescently labeled DNA oligonucleotides that hybridize to fungal 23S ribosomal RNA (rRNA), which is distributed throughout the fungal cytoplasm. Because host tissues are fixed in a manner that preserves the three-dimensional architecture of the gut, including the host mucosa, digestive material, the bacterial microbiota, and mucus within the gut lumen, this technique permits the localization of fungal cells with respect to these landmarks when stained. The FISH technique compares favorably to traditional histological stains for fungi, such as Periodic Acid Schiff (PAS) or Gomori's Methenamine-Silver (GMS), as well as commercially available antifungal antibodies, because these reagents are not specific for C. albicans. Moreover, standard fixatives remove the mucus layer and disrupt other contents of the gut lumen 1. Provide housing for 18−21 g male or female mice (8−10 weeks old) as approved by the local IACUC. Use autoclaved food and water starting on the first day. NOTE: The use of sterilized cages, bedding, food, and water reduces the risk of contamination with antibiotic-resistant environmental bacteria that can potentially displace C. albicans from the gut. Further, depending on the experimental question, individual housing of animals should be considered because mice are coprophagic and gut contents will be shared among cohoused animals. 2. The following day, replace the autoclaved drinking water with autoclaved water containing 5% glucose, 1,500 U/mL penicillin G, and 2 mg/mL streptomycin. 3. For convenience, prepare 200x antibiotic stock solutions ( Table 1) in advance, filter sterilize, and freeze at -20 °C. 4. Maintain animals on antibiotics for one week.
1. On days 3 and 6 after antibiotics have been started, assess each animal's feces for contamination with antibiotic-resistant aerobic bacteria. Holding an animal with one hand, place an uncapped microfuge tube near the anus and collect at least one fecal pellet. 2. Resuspend each fecal pellet in 1 mL of sterile water and plate 100 µL on Luria broth (LB), yeast extract peptone dextrose (YEPD), or brain heart infusion (BHI) plus blood agar plates. Incubate the plates overnight in a standard incubator (not anaerobic) at 37 °C and assess for bacterial growth. NOTE: Plates should exhibit minimal growth (0−20 colonies). If >20 colonies of bacteria are recovered from animals treated with penicillin and streptomycin, then it is unlikely that high-level colonization with C. albicans will be established and the experiment should be aborted.
5.
Three days prior to gavage, streak C. albicans from frozen glycerol stocks to YEPD + 2% agar plates and incubate at 30 °C for 2 days. 6. One day before gavage, inoculate one colony of each C. albicans strain to be tested into 5 mL of liquid YEPD. Incubate at 30 °C overnight with shaking. 7. The morning of gavage, dilute the saturated culture of C. albicans to an optical density at 600 nm (OD 600 ) of 0.1 in 100 mL of YEPD prewarmed to 30 °C. Shake in an orbital shaker at 200 rpm at 30 °C for between 4 h and 5 h until OD 600 reaches 1 (mid-log growth). 8. Transfer each 100 mL culture to two 50 mL conical tubes and centrifuge at 3,000 x g for 5 min at room temperature (RT). NOTE: C. albicans propagates relatively slowly at RT. If adapting this protocol for another species, the inocula may need to be kept on ice to prevent continued growth. 9. Discard the supernatant, resuspend the pelleted cells in 20 mL of sterile saline per 50 mL of culture, and pool the duplicate resuspended pellets into single conical tubes. Centrifuge at 3,000 x g for 5 min. 10. Discard the supernatant and resuspend in 20 mL of sterile saline. Vortex briefly and remove 20 µL for OD 600 measurement. Dilute 1:50 in sterile normal saline. Centrifuge the remaining resuspended cells at 3,000 x g for 5 min. 11. Discard the supernatant. For an inoculum size of 1 x 10 8 CFU, resuspend the pelleted cells to approximately 5 x 10 8 CFUs/mL in sterile normal saline based on the estimated concentration determined from OD 600 measurement. NOTE: Typically, an OD 600 of 1 corresponds to ~1 x 10 7 yeast cells/mL. This value may vary by spectrophotometer and should be verified. If a change in concentration is desired for infections with a different microorganism, plan for an inoculum volume of ≤10 µL/g mouse to minimize discomfort to the animal. 12. Verify the concentration of the inoculum by counting a 1:1,000 dilution with a hemocytometer. Adjust the volume of cells to be gavaged based on the concentration determined using the hemocytometer. 13. Using an animal feeding needle ( Figure 1A) , gavage each animal with the calculated volume of a given inoculum. See steps 1.13.1−1.13.8 for the gavage procedure. NOTE: Training for gavage should be obtained from an experienced practitioner, and the procedure should be mastered in advance. A successful procedure for a single animal typically takes no longer than 1 min. 1. Attach an autoclaved animal-feeding needle to a 1 mL syringe and fill the syringe with one gavage volume, removing any air bubbles to avoid an inaccurate dose. Place on a sterile surface. 2. Secure the animal for gavage. Hold the animal at the base of the tail with the dominant hand and slide nondominant hand up the animal's back to the loose skin just behind the ears. 3. Using the forefinger and thumb of the nondominant hand, gather the loose skin together tightly; this is the "scruff". Pick up the animal by its scruff and loop small finger of the same (nondominant) hand around the tail to immobilize animal against the palm of the hand. Gently extend the animal's head so that its head and body (and therefore neck and esophagus) are in a straight line. NOTE: Attempting a gavage while the animal's body is bent or twisted may result in complications such as esophageal perforation and death of the animal. 4. Pick up the syringe with the dominant hand and hold perpendicular to the animal, with the curved needle pointing down (Figure 1B) .
Using the ball of the needle, gently hook an inside corner of the mouth, gently advance the needle along the side of the mouth to the back of the throat, and finally move the needle to the center. NOTE: Introducing the needle along a lateral path helps to avoid resistance from the animal's teeth and tongue. 5. Once the ball of the needle is at the back of throat, tilt the needle up so that it is parallel with the animal's body line ( Figure 1C) . NOTE: At this point, the animal will exhibit a gag reflex. This is a good sign that indicates that the needle is positioned correctly, and the gagging motion helps to guide the needle down the esophagus. If there is no gag reflex, the needle may be in the trachea rather than the esophagus. Gently withdraw the needle and proceed back to step 1.13.1. 6. Allow the animal to swallow the inoculum until only a few millimeters remain visible (Figure 1D) . Advance the needle smoothly.
NOTE: If the needle does not advance, avoid using force, which can damage the esophagus. Sometimes advancing the last half centimeter will require an extra-large gag from the animal. If the needle seems to be stuck, slowly withdraw it and try again from step 1.13.4. 7. Test that the ball of needle is in the correct location (stomach) by gently advancing the plunger. If there is no resistance, continue delivering the inoculum. Once the inoculum has been administered, slowly withdraw the needle. 8. Replace the animal in its cage and continue to monitor the animal for 5−10 min for signs of labored breathing or distress. Verify that the animal resumes normal activity soon after gavage. 9. If the same inoculum will be used with the next animal, clean the needle with an alcohol wipe. Proceed back to step 1.13.1. If a different inoculum will be used, use a new needle and proceed back to step 1.13.1. NOTE: It is important to inspect animals the day after gavage. Animals exhibiting signs of distress (e.g., hunched posture, labored breathing) should be humanely euthanized, as they have likely suffered esophageal rupture, damage to the lungs, or another internal injury from which recovery is unlikely.
14.
Following gavage of the animals, plate dilutions of the inocula for dose verification. (Figure 2A) . Spray the animal with 70% ethanol to clean the fur and minimize sticking to the tools. 5. Using blunt-ended forceps, pinch a section of abdominal skin with nondominant hand. Using scissors with dominant hand, incise the skin and underlying fascia near the base of the pelvis. Extend the incision in a U shape along each side of the peritoneal cavity and up to the rib cage.
Preparation of Gastrointestinal Tissues for Histology
Lift the skin out of the way. 6. Using a pencil, prelabel histology cassettes for the GI segments to be assessed. For example, for each animal, label separate cassettes as "stomach," "proximal small intestines," "mid small intestines," "distal small intestines," "cecum," and "large intestines." Place a foam pad on the bottom of each cassette (Figure 2A) . NOTE: Figure 2B outlines suggested sections to place in cassettes. 7. Using blunt-ended forceps, gently extract the cecum from the peritoneal cavity. Use scissors to sever connections between the cecum and the small and large intestines. NOTE: Cecal tissue is very delicate and easy to rupture. Take care when manipulating. 8. Place the entire cecum into a histology cassette so that it is untwisted and lays flat (Figure 2C) . Place a second foam pad on top and close the cassette. Place the cassette into a screw cap jar containing methacarn. 9. Excise a section of the large intestines that contains 1−2 fecal pellets, with a length less than that of the cassette. 10. Place the tissue section into the cassette, keeping the tissue flat and untwisted. Overlay with a second foam pad and close the cassette.
Place the cassette into methacarn. 11. For each section of the small intestines to be sampled, excise a 1−2 cm segment that contains some digestive material. 12. Place the segment into a histology cassette, keeping the tissue flat and untwisted. Overlay with a second foam pad and close the cassette.
Place the cassette into methacarn. 13. For the stomach, sever the connections to the esophagus and small intestines. Place in a cassette, keeping the tissue flat and untwisted.
Overlay with a second foam pad and close the cassette. Place the cassette into methacarn. 14. Leave the cassettes in methacarn solution at RT for at least 3 h and less than 2 weeks. NOTE: There are several points during which the fixed GI segments can be transferred to a commercial histology service. These tissues can be difficult to section without disruption of luminal contents, and optimal results will be obtained by an experienced technician. If the commercial service is willing to perform washes prior to embedding the tissues in paraffin, the cassettes can be sent at this stage along with instructions for step 2.16. 15. Begin melting enough paraffin wax to cover all tissue cassettes in a large beaker in a preheated 70 °C hybridization oven. 16 . Following fixation, remove the foam pads and return each intact tissue section back into its cassette. Wash the tissues with the following solutions at RT with shaking: twice for 35 
Representative Results
Following the instructions provided, the outcome of this technique will be fluorescent labelling of nuclei in the host epithelium, mucus, and C. albicans in sectioned GI tissues. Wild type Candida albicans cells should appear as either round, unicellular yeast cells or highly elongated, sometimes branching, multicellular hyphae (cell-cell divisions will not be apparent in the hyphae). Mutants of C. albicans may additionally appear as smaller, slightly elongated "gray" yeasts or as larger, slightly elongated "GUT" (gastrointestinal-induced transition) or "opaque" yeasts. Figure 3A shows fluorescence and phase images of fixed, permeabilized, in vitro-propagated hyphae. Hypha formation was induced with liquid Lee's medium 18 with 2% N-acetylglucosamine, pH 6.8 at 37 °C. Figure 3B shows fluorescence and phase images of fixed, permeabilized, in vitro-propagated yeast cells. Figure 3C ,D shows fixed, permeabilized, in vitro-propagated GUT cells and opaque cells, respectively. GUT and opaque cell types are morphologically indistinguishable except when visualized by scanning electron microscopy. Please note that FISH staining of in vitropropagated cells will be suboptimal if the cells are not well permeabilized. An example of weak and diffuse staining is shown in Figure 3C . For best results, cell fixation and permeabilization conditions should be determined empirically for each cell type and species to be investigated. Fortunately, the recommended protocol for visualizing C. albicans in sectioned tissues produces more consistent permeabilization. Figure 3E -G depict C. albicans in mouse large intestines, stained with the C. albicans-specific probe (Figure 3E) or the panfungal probe (Figure 3F,G) . C. albicans appears red in these images, host cell nuclei are blue, and the mucus layer is green. Both round yeasts and highly elongated hyphae (white arrowheads) occur in the large intestines. Please note that staining is brighter with the panfungal probe. Figure 3G depicts a ume6 mutant in the same compartment, stained with the panfungal probe. Ume6 encodes a transcription factor that is required for hypha formation under in vitro conditions 19 . Interestingly, the yeast-locked phenotype displayed by this mutant under in vitro conditions is not recapitulated within the gut, suggesting that a redundant factor must be activated within the host 12 . Figure 4 depicts the appearance of wild type C. albicans in different segments of the murine GI tract, including the regions immediately adjacent to the host mucosa and more central regions of the gut lumen. 
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Discussion
The method described here allows for visualization of C. albicans yeasts and hyphae in the GI tracts of commensally colonized mice of any sex or strain. The FISH probe hybridizes to 23S rRNA, which is distributed throughout the fungal cytoplasm. Our method was adapted from a previously reported protocol for visualizing gut bacteria 20 . Because C. albicans changes its morphology within the host, the method is useful to monitor fungal cell shape as well as localization. For example, we have used this method to disprove the hypothesis that yeasts predominate throughout the digestive tract, and to expose discrepancies between the in vivo and in vitro phenotypes of certain "filamentation-defective" mutants 12 .
Several mouse models exist for C. albicans commensal colonization. The microbiota of laboratory mice and humans are distinct and, in mice, the use of antibiotics or a specialized diet is required to establish stable colonization. Treatment with antibiotics also enhances C. albicans colonization of humans and is a major risk factor for disseminated disease 10 . The antibiotics used in this study are relatively inexpensive and yield reliable decreases in the bacterial microbiota. Note that antibiotics are used to decrease the burden of antagonistic bacterial species, not to eliminate all bacteria from the animals. If researchers wish to study C. albicans-host interactions in the absence of bacteria or to avoid the use of antibiotics or a special diet, germ-free animals can be substituted for conventionally reared animals; however, gnotobiotic mice exhibit certain immune and anatomic abnormalities and therefore may not be suitable for all purposes.
Several steps are important for successful FISH staining: The recommended fixation method is critical to preserve the structural integrity of GI tissues, particularly the fragile contents of the gut lumen, such as the mucus layer and the three-dimensional organization of fungi and bacteria 16 .
Please note that many commonly used fixation solutions that contain water are highly damaging to the luminal architecture. The fixatives and solutions for post-fixation washes recommended in this protocol do not contain water, and it is important to avoid contamination with water. Another critical step is the hybridization step, where it is important to avoid evaporation of the hybridization solution during incubation of slides in the hybridization oven. We suggest placing the slides in a watertight container to avoid this problem. Alternatively, one can use watertight hybridization chambers such as those originally used for hybridization of microarrays.
A C. albicans-specific FISH probe is described in this protocol. However, because many laboratory-reared mice do not contain C. albicans or other fungi as part of their natural gut microbiota, a panfungal probe may specifically stain C. albicans in experimentally colonized animals. Substitution of a panfungal probe may be desirable because of its superior hybridization characteristics and higher signal-to-noise ratio. If the panfungal probe is used as a pseudospecific probe for C. albicans, it is important to document a lack of staining in uninfected animals (i.e., treated with antibiotics but not C. albicans). Staining of a noncolonized control animal is also useful to assess background staining that may result from adherence of FISH probes to food particulates. Overall, the use of FISH probes offers enhanced specificity over most other methods of staining fungi, such as Calcofluor white (which stains chitin, a cell wall component that may vary between cell types), GMS, or commercially available antifungal antibodies. Moreover, FISH staining allows for costaining of multiple organisms using differentially labeled FISH probes to species-specific rRNAs.
One caveat of this technique is that certain C. albicans yeast cell types appear very similar by FISH (for example, the opaque and GUT cell types). To distinguish among these cell types, it would be useful to develop hybridization probes to cell type-specific fungal mRNAs. Nevertheless, in its current form, the FISH technique has already revealed surprising discrepancies between the in vivo and in vitro behaviors of C. albicans mutants evaluated under both conditions 12 , indicating complex interactions in the natural commensal environment that are not adequately mimicked by existing in vitro assays. Further studies of different C. albicans stains in additional wild type and mutant hosts are likely to yield additional insights into fungal-host interactions. In particular, it will be instructive to profile C. albicans in models of inflammatory bowel disease, which is associated with high titers of C. albicans in humans 21 , and other models of C. albicans overgrowth and disease. The FISH technique may also be combined with immunohistochemistry to stain specific host cells. Overall, the method presented here provides a reasonably quick and reliable means to determine C. albicans localization and morphology within the mammalian GI tract.
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